OYST Insider Trading Activity and SEC Form 4 Filings
OYST insider trading summary
No open-market insider purchases or sales of Oyster Point Pharma, Inc. (OYST) have been reported on SEC Form 4 in the past 12 months.
Latest OYST insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 18, 2021 | William J Phd Link | Director | Sell | $23K (1,531 @ $15.09) |
| Oct 18, 2021 | William J Phd Link | Director | Sell | $3.7M (242,943 @ $15.09) |
| Oct 18, 2021 | William J Phd Link | Director | Sell | $28K (1,912 @ $14.63) |
| Oct 18, 2021 | Versant Vantage I GP-GP, LLC | 10% Owner | Sell | $4.4M (303,614 @ $14.63) |
| Oct 18, 2021 | Versant Vantage I GP, L.P. | 10% Owner | Sell | $4.4M (303,614 @ $14.63) |
| Oct 18, 2021 | Versant Ventures VI GP, L.P. | 10% Owner | Sell | $4.4M (303,614 @ $14.63) |
| Oct 18, 2021 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | $4.4M (303,614 @ $14.63) |
| Oct 18, 2021 | Versant Vantage I, L.P. | 10% Owner | Sell | $4.4M (303,614 @ $14.63) |
| Oct 18, 2021 | Versant Ventures VI GP-GP, LLC | 10% Owner | Sell | $28K (1,912 @ $14.63) |
| Oct 18, 2021 | William J Phd Link | Director | Sell | $4.4M (303,614 @ $14.63) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.